Literature DB >> 15978090

Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin.

W Li1, X Zheng, J Gu, J Hunter, G L Ferrell, F Lupu, N L Esmon, C T Esmon.   

Abstract

Previous studies have shown that blocking endothelial protein C receptor (EPCR)-protein C interaction results in about an 88% decrease in circulating activated protein C (APC) levels generated in response to thrombin infusion and exacerbates the response to Escherichia coli. To determine whether higher levels of EPCR expression on endothelial cells might further enhance the activation of protein C and protect the host during septicemia, we generated a transgenic mouse (Tie2-EPCR) line which placed the expression of EPCR under the control of the Tie2 promoter. The mice express abundant EPCR on endothelial cells not only on large vessels, but also on capillaries where EPCR is generally low. Tie2-EPCR mice show higher levels of circulating APC after thrombin infusion. Upon infusion with factor Xa and phospholipids, Tie2-EPCR mice generate more APC, less thrombin and are protected from fibrin/ogen deposition compared with wild type controls. The Tie2-EPCR animals also generate more APC upon lipopolysaccharide (LPS) challenge and have a survival advantage. These results reveal that overexpression of EPCR can protect animals against thrombotic or septic challenge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978090     DOI: 10.1111/j.1538-7836.2005.01385.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  64 in total

1.  Factor VIIa binding to endothelial cell protein C receptor: differences between mouse and human systems.

Authors:  Prosenjit Sen; Curtis A Clark; Ramakrishnan Gopalakrishnan; Ulla Hedner; Charles T Esmon; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Thromb Haemost       Date:  2012-02-28       Impact factor: 5.249

2.  Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.

Authors:  Shiva Keshava; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2020-06-25       Impact factor: 5.824

3.  The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.

Authors:  Giulia Pavani; Lacramioara Ivanciu; Armida Faella; Oscar A Marcos-Contreras; Paris Margaritis
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

4.  Factor X binding to endothelial cell protein C receptor: comparison with factor VIIa and activated protein C.

Authors:  Prosenjit Sen; Ramesh Nayak; Curtis A Clark; Ramakrishnan Gopalakrishnan; Charles T Esmon; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

5.  Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.

Authors:  Marlene E Starr; Junji Ueda; Hitoshi Takahashi; Hartmut Weiler; Charles T Esmon; B Mark Evers; Hiroshi Saito
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

6.  EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.

Authors:  Jhansi Magisetty; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113

7.  Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.

Authors:  Laurent Burnier; José A Fernández; John H Griffin
Journal:  Blood Cells Mol Dis       Date:  2013-02-04       Impact factor: 3.039

8.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

9.  Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.

Authors:  Marcel Schouten; Koenraad F van der Sluijs; Bruce Gerlitz; Brian W Grinnell; Joris J T H Roelofs; Marcel M Levi; Cornelis van 't Veer; Tom van der Poll
Journal:  Crit Care       Date:  2010-04-14       Impact factor: 9.097

10.  Analysis of endothelial protein C receptor functionality on living cells'.

Authors:  E Ducros; S Mirshahi; C Bermot; M Mirshahi
Journal:  Open Biochem J       Date:  2009-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.